Blueriver Acquisition CORP

BlueRiver Acquisition Corp. shareholders overwhelmingly approved an amendment to extend the deadline for completing a business combination until August 2, 2026.

BlueRiver Acquisition Corp. successfully obtained shareholder approval to extend the deadline for completing a business combination by up to 12 months.

BlueRiver Acquisition Corp. has been delisted from the NYSE American after withdrawing its appeal, with trading of its shares and units suspended.

BlueRiver Acquisition Corp.'s merger agreement with Spinal Stabilization Technologies has been terminated, and the company's warrants are facing delisting from NYSE American.

BlueRiver Acquisition Corp. has amended its merger agreement to extend the closing date to March 31, 2024, while also facing potential delisting from the NYSE American.

BlueRiver Acquisition Corp. has increased the required deposit into its trust account for each unredeemed public share to $0.025 per month for a potential extension of its termination date.

Blueriver Acquisition Corp.'s Q3 2024 report reveals a net loss of $110,000, ongoing challenges with its business combination, and the delisting of its securities from the NYSE American.

BlueRiver Acquisition Corp. reported a net income of $1.1 million for the three months ended June 30, 2024, but faces significant challenges including a delisting from NYSE American and the termination of a merger agreement.

BlueRiver Acquisition Corp. reported a net loss of $2.5 million for the quarter ended March 31, 2024, as it continues to pursue a business combination.

BlueRiver Acquisition Corp.'s annual report outlines its financial status, ongoing efforts to complete a business combination with Spinal Stabilization Technologies, and the challenges faced as a blank check company.

BlueRiver Acquisition Corp. successfully obtained shareholder approval to extend the deadline for completing a business combination by up to 12 months, providing additional time to finalize a merger, share exchange, asset acquisition, share purchase, reorganization, or similar transaction.

BlueRiver Acquisition Corp.'s Class A ordinary shares and units have been suspended from trading and delisted from NYSE American after the company withdrew its appeal against the delisting determination.

BlueRiver Acquisition Corp. has terminated its merger agreement with Spinal Stabilization Technologies and faces delisting of its warrants from NYSE American due to abnormally low prices.

BlueRiver Acquisition Corp. is seeking shareholder approval to extend its deadline for completing an initial business combination by up to 12 months, from August 2, 2025, to August 2, 2026, to allow more time for a suitable acquisition.

BlueRiver Acquisition Corp. is seeking shareholder approval to extend the deadline for completing a business combination, facing potential liquidation and delisting from NYSE American.

Clear Street LLC has filed an amendment to terminate its Schedule 13G filing for BlueRiver Acquisition Corp. common stock, as its beneficial ownership no longer meets the 5% reporting threshold.

Clear Street LLC has reported beneficial ownership of 110,123 shares, representing 12.3% of the outstanding common stock of BlueRiver Acquisition Corp., as of May 5, 2026.